Skip to main content

Table 1 Inclusion and exclusion criteria

From: Short-course antibiotic regimen compared to conventional antibiotic treatment for gram-positive cocci infective endocarditis: randomized clinical trial (SATIE)

Inclusion criteria
I. Definite IE, according to modified ESC 2015 criteria [6], caused by gram-positive cocci (staphylococci, streptococci and enterococci), including native, prosthetic valve IE and cardiac device-related IE.
II. 18 years old or older.
III. Absence of fever, microbiological or analytical findings suggesting persistent infection in the last 24 h prior to randomization.
IV. Absence of locally uncontrolled infection signs (abscess, pseudoaneurysm, fistula, enlarging vegetation) at randomization, confirmed by recent transesophageal echocardiography (performed within 48 h of randomization).
V. Women of childbearing potential who will agree to the use of effective contraceptive methods while on antibiotic treatment.
Exclusion criteria
I. Patients who have received appropriate parenteral antibiotic therapy for infective endocarditis for more than 12 days.
II. Patients not suitable to be discharged after 10 days of conventional treatment, due to clinical reasons (sequels of stroke that prevent discharge, progressive renal failure, hepatic failure, heart failure).
III. Patients receiving chemotherapy or immunosuppressive therapy.
IV. Pregnant or breastfeeding women.
V. Need of prolonged antibiotic therapy due to spondylodiscitis or other septic complication.
VI. Absence of patient’s ability or commitment to continue follow-up after being discharged from hospital.
VII. Inability to give informed consent to participation.
VIII. Cognitive impairment or lack of language skills needed to complete the questionnaires.
IX. Patients who meet urgent cardiac surgery ESC criteria but are considered inoperable due to high surgical risk.